News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Davidson Michael H.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2022 |
4
| Davidson Michael H. (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 65,430 shares
@ $0 |
|
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2020 |
4
| Davidson Michael H. (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Bought 55,525 shares
@ $1.8, valued at
$99.9k
|
|
| 08/12/2020 |
4
| Davidson Michael H. (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 51,063 shares
@ $2.35, valued at
$120k
|
|
| 08/12/2020 |
3
| Davidson Michael H. (Director) has filed a Form 3 on CALADRIUS BIOSCIENCES, INC. |
| 07/18/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/11/2013 |
3
| Davidson Michael H. (Executive VP & CMO) has filed a Form 3 on Omthera Pharmaceuticals, Inc. |
|
|